West Paces Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.9K | Buy |
+1,895
| New | +$103K | 0.01% | 231 |
|
|
2026
Q1 | – | Sell |
-2,290
| Closed | -$218K | – | 200 |
|
|
2025
Q4 | $218K | Buy |
2,290
+178
| +8% | +$17.5K | 0.04% | 154 |
|
|
2025
Q3 | $206K | Sell |
2,112
-100
| -5% | -$10.4K | 0.04% | 148 |
|
|
2025
Q2 | $238K | Hold |
2,212
| – | – | 0.05% | 133 |
|
|
2025
Q1 | $223K | Hold |
2,212
| – | – | 0.05% | 130 |
|
|
2024
Q4 | $198K | Hold |
2,212
| – | – | 0.05% | 133 |
|
|
2024
Q3 | $185K | Sell |
2,212
-135
| -6% | -$10.6K | 0.05% | 145 |
|
|
2024
Q2 | $181K | Hold |
2,347
| – | – | 0.05% | 127 |
|
|
2024
Q1 | $161K | Sell |
2,347
-28
| -1% | -$1.8K | 0.04% | 146 |
|
|
2023
Q4 | $137K | Sell |
2,375
-190
| -7% | -$10.1K | 0.04% | 148 |
|
|
2023
Q3 | $135K | Hold |
2,565
| – | – | 0.04% | 142 |
|
|
2023
Q2 | $139K | Hold |
2,565
| – | – | 0.04% | 147 |
|
|
2023
Q1 | $128K | Buy |
2,565
+747
| +41% | +$35.2K | 0.04% | 149 |
|
|
2022
Q4 | $84.1K | Sell |
1,818
-140
| -7% | -$6.06K | 0.03% | 182 |
|
|
2022
Q3 | $75.8K | Hold |
1,958
| – | – | 0.03% | 183 |
|
|
2022
Q2 | $73K | Hold |
1,958
| – | – | 0.02% | 191 |
|
|
2022
Q1 | $86.7K | Buy |
1,958
+1,580
| +418% | +$68.5K | 0.03% | 184 |
|
|
2021
Q4 | $16.1K | Sell |
378
-182
| -33% | -$7.65K | 0.01% | 335 |
|
|
2021
Q3 | $24.3K | Buy |
560
+238
| +74% | +$10.5K | 0.01% | 269 |
|
|
2021
Q2 | $13.8K | Hold |
322
| – | – | 0.01% | 325 |
|
|
2021
Q1 | $12.4K | Sell |
322
-338
| -51% | -$12.8K | 0.01% | 314 |
|
|
2020
Q4 | $23.7K | Hold |
660
| – | – | 0.01% | 238 |
|
|
2020
Q3 | $25.2K | Hold |
660
| – | – | 0.01% | 223 |
|
|
2020
Q2 | $23.2K | Hold |
660
| – | – | 0.01% | 240 |
|
|
2020
Q1 | $21.5K | Buy |
660
+195
| +42% | +$7.62K | 0.01% | 238 |
|
|
2019
Q4 | $21K | Hold |
465
| – | – | 0.01% | 269 |
|
|
2019
Q3 | $18.9K | Hold |
465
| – | – | 0.01% | 262 |
|
|
2019
Q2 | $20K | Hold |
465
| – | – | 0.01% | 245 |
|
|
2019
Q1 | $17.8K | Hold |
465
| – | – | 0.01% | 260 |
|
|
2018
Q4 | $16.4K | Hold |
465
| – | – | 0.01% | 260 |
|
|
2018
Q3 | $17.9K | Hold |
465
| – | – | 0.01% | 268 |
|
|
2018
Q2 | $15.2K | Hold |
465
| – | – | 0.01% | 285 |
|
|
2018
Q1 | $12.7K | Hold |
465
| – | – | 0.01% | 295 |
|
|
2017
Q4 | $11.5K | Hold |
465
| – | – | 0.01% | 320 |
|
|
2017
Q3 | $13.6K | Hold |
465
| – | – | 0.01% | 305 |
|
|
2017
Q2 | $12.9K | Hold |
465
| – | – | 0.01% | 302 |
|
|
2017
Q1 | $11.6K | Hold |
465
| – | – | 0.01% | 311 |
|
|
2016
Q4 | $10.1K | Buy |
+465
| New | +$10.1K | 0.01% | 335 |
|
Other funds holding BSX
West Paces Advisors's BSX Position: Q2 2026 in Review
West Paces Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 1,895 shares worth $80.9K. The stake represents 0.01% of the portfolio and ranks #231 among its holdings. This is a return to the name: West Paces Advisors previously reported a position in BSX as recently as Q4 2025.
West Paces Advisors first reported a position in BSX in Q4 2016 and has held it in 38 quarters since. The position peaked at $238K in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- West Paces Advisors held 1,895 shares of Boston Scientific worth $80.9K as of Q2 2026.
- Boston Scientific was a new West Paces Advisors position in Q2 2026.
- Boston Scientific made up 0.01% of West Paces Advisors's portfolio in Q2 2026, its #231 holding.
- West Paces Advisors first reported a position in Boston Scientific in Q4 2016 and has held it in 38 quarters since.
- West Paces Advisors's Boston Scientific position peaked at $238K in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.